期刊文献+

卡前列素氨丁三醇联合宫腔球囊放置术治疗前置胎盘产后出血的临床效果

Clinical Effect of Carboprost Tromethamine Combined with Balloon Placement in the Treatment of Placenta Previa Postpartum Hemorrhage
下载PDF
导出
摘要 目的探讨卡前列素氨丁三醇素联合宫腔球囊放置术治疗前置胎盘产后出血的临床效果。方法选取成武县人民医院2018年1月—2021年12月收治的72例前置胎盘产后出血患者为研究对象,按随机数字表法分为对照组及观察组,每组36例。两组均行宫腔球囊放置术,在此基础上,对照组采用缩宫素治疗,观察组采用卡前列素氨丁三醇治疗。比较两组患者的止血效果、出血情况、凝血功能及生命体征。结果观察组的止血总有效率为94.44%,高于对照组的77.78%,差异有统计学意义(P<0.05)。观察组的产后2、6、12、24 h出血量分别为(385.25±34.16)mL、(658.41±50.24)mL、(862.41±75.41)mL、(1089.65±105.25)mL,均少于对照组的(425.35±45.41)mL、(708.63±52.47)mL、(928.47±80.36)mL、(1254.63±125.74)mL,组间差异有统计学意义(P<0.05)。治疗24 h后,观察组的凝血酶原时间、活化部分凝血活酶时间分别为(11.53±1.22)s、(37.05±3.12)s,均短于对照组的(13.42±1.25)s、(40.18±3.85)s,组间差异有统计学意义(P<0.05)。治疗24 h后,观察组的收缩压、舒张压均高于对照组,心率慢于对照组,组间差异有统计学意义(P<0.05)。结论卡前列素氨丁三醇联合宫腔球囊放置术的止血效果更佳,可减少前置胎盘患者的产后出血量,改善其凝血功能,稳定其心率及血压。 Objective To investigate the clinical effect of carboprost tromethamine combined with balloon placement in the treatment of placenta previa postpartum hemorrhage.Methods A total 72 placenta previa patients with postpartum hemorrhage admitted to Chengwu County People's Hospital from January 2018 to December 2021 were selected as the study objects and were divided into a control group and an observation group according to random number table method,with 36 cases in each group.Uterine balloon placement was performed in both groups.On this basis,the control group was treated with oxytocin,and the observation group was treated with carboprost tromethamine.The hemostatic effect,bleeding situation,coagulation function and vital signs of the two groups were compared.Results The total effective rate of hemostasis in the observation group was 94.44%,which was higher than 77.78%in the control group,the difference was statistically significant(P<0.05).The postpartum blood loss at 2,6,12 and 24 h in the observation group were(385.25±34.16)mL,(658.41±50.24)mL,(862.41±75.41)mL and(1089.65±105.25)mL,respectively,which were less than(425.35±45.41)mL,(708.63±52.47)mL,(928.47±80.36)mL and(1254.63±125.74)mL in the control group,the differences between the groups were statistically significant(P<0.05).After 24 h of treatment,the prothrombin time and activated partial thromboplastin time in the observation group were(11.53±1.22)s and(37.05±3.12)s,respectively,which were shorter than(13.42±1.25)s and(40.18±3.85)s in the control group,the differences between the two groups were statistically significant(P<0.05).After 24 h of treatment,the systolic blood pressure and diastolic blood pressure in the observation group were higher than those in the control group,and the heart rate was slower than that in the control group,the differences between the two groups were statistically significant(P<0.05).Conclusion Carboprost tromethamine combined with balloon placement has better hemostatic effect,can reduce postpartum blood loss,improve coagulation function,and stabilize heart rate and blood pressure in placenta previa patients.
作者 宋敏 SONG Min(Department of Obstetrics and Gynecology,Chengwu County People's Hospital,Heze 274000,China)
出处 《反射疗法与康复医学》 2024年第16期152-155,共4页 Reflexology And Rehabilitation Medicine
关键词 前置胎盘 产后出血 卡前列素氨丁三醇 缩宫素 宫腔球囊放置术 Placental previa Postpartum hemorrhage Carboprost tromethamine Oxytocin Uterine balloon placement
  • 相关文献

参考文献10

二级参考文献106

  • 1方文静.缩宫素静脉滴注与宫体注射欣母沛防治剖宫产术后出血的效果观察[J].实用妇科内分泌电子杂志,2019,0(22):7-8. 被引量:1
  • 2Oppenheimer L, Society of Obstetricians and Gynaecologists ofCanada. Diagnosis and management of placenta previa. J ObstetGynaecol Can, 2007, 29:261-273.
  • 3Royal College of Obstetricians and Gynaecologists. Placentapraevia, placenta preavia accrete and vasa praevia diagnosis andmanagement. Green-top Guideline No. 27. January 2011 [ EB/OL]. [ 2012-06-18] http://www.rcog.org.uk/womens_health/clinical-guidance/ placenta-praevia-and-placenta-praevia-accreta~diagnosis-and-manageme.
  • 4Cho JY, Lee YH, Moon MH, et al. Difference in migration ofplacenta according to the location and type of placenta previa. JClin Ultrasound, 2008,36:79-84.
  • 5Rao KP, Belogolovkin Y, Yankowitz J, et al. Abnormalplacentation: evidence-based diagnosis and management oiplacenta previa, placenta accreta, and vasa previa. ObstetGynecol Surv, 2012, 67:503-519.
  • 6James KK, Steer PJ, Weiner CP, et al.高危妊娠.段涛,杨慧霞,译.3版.北京:人民卫生出版社,2008:1126.
  • 7Bose DA, Assel BG, Hill JB, et al. Maintenance tooolytics forpreterm symptomatic placenta previa : a review. Am J Perinatol,2011,28:45-50.
  • 8Sharma A, Suri V,Gupta I. Tocolytic therapy in conservalivemanagement of symptomatic placenta previa. Int J GynaecolObstet, 2004, 84:109-113.
  • 9Stafford IA, Dashe JS, Shivvers SA, et al. Ultrasonographiccervical length and risk of hemorrhage in pregnancies with placentaprevia. Obstet Gynecol, 2010 , 116:595-600.
  • 10Ohira S, Kikuchi N, Kobara H, et al. Predicting the route ofdelivery in women with low-lying placenta using transvaginalultrasonography : significance of placental migration and marginalsinus. Gynecol Obstet Invest,2012, 73 :217-222.

共引文献528

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部